B cell depletion therapies in autoimmune disease: advances and mechanistic insights

In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather active participants in autoimmune aetiology. This has been fuelled in part by the clinical success of B cell depletion therapies (BCDTs). Originally conceived as a method of eliminating cancerous B cells, BCD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dennis S. W., Rojas, Olga L., Gommerman, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737718/
https://www.ncbi.nlm.nih.gov/pubmed/33324003
http://dx.doi.org/10.1038/s41573-020-00092-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737718/
https://www.ncbi.nlm.nih.gov/pubmed/33324003
http://dx.doi.org/10.1038/s41573-020-00092-2

Ejemplares similares